Overview
- 18 inspections across 18 sites are on record.
- 55 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-20.
At a glance
Inspections
18
Sites
18
Observations
55
Career since
Dec 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Talbot's Pharmaceuticals Family Products, LLC | 20 May 2026 | Human Drugs | View 483 → |
| Microchem Laboratory | 30 Apr 2026 | Human Drugs | View 483 → |
| Global Packaging Systems, Inc | 9 Apr 2026 | Human Drugs | View 483 → |
| Eosera, Inc. | 20 Mar 2026 | Human Drugs | View 483 → |
| Quality CDMO | 12 Feb 2026 | Human Drugs |
Sites inspected
Talbot's Pharmaceuticals Family Products, LLCMonroe, United States1 insp.
Microchem LaboratoryRichardson, United States1 insp.
Global Packaging Systems, IncFort Worth, United States1 insp.
Eosera, Inc.Fort Worth, United States1 insp.
Quality CDMOFort Worth, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jeffrey T Prosterman4 shared
Ronda R Loyd Jones4 shared
Stephon D Tillis3 shared
Margaret M Annes2 shared
Mercedes N Overton2 shared
Demario L Walls2 shared
Oluwasefunm Agbanigo1 shared
Mickell Smith1 shared
Brittny C Cargo1 shared
Inga M Warr1 shared
Full investigator report
Get the verbatim findings behind Milton J De Jesus Tavarez's 55 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site